633 results on '"Osada, Taro"'
Search Results
2. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
3. Interleukin-10 induces TNF-driven apoptosis and ROS production in salivary gland cancer cells
4. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
5. AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
6. Hidden Footprints in Ascites: Lessons From a Mystery Enduring for 200 Years.
7. The total character count: Interleukin-10 induces TNF-driven apoptosis and ROS production in salivary gland cancer cells
8. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
9. Can a Solitary Juvenile Polyp Be Regarded as a Nonmalignant Polyp?
10. The multifaceted role of plasminogen in inflammation
11. Remission Factors for Ustekinumab Treatment of Ulcerative Colitis: A Multicenter Retrospective Study of Real-World Data in Japan.
12. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
13. Diffuse Esophageal Glycogenic Acanthosis: Not Always Incidental
14. Transgastric Jejunostomy (PEG-J) for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel: An Approach for Parkinson\'s Disease Treatment
15. Distinct endoscopic characteristics of sessile serrated adenoma/polyp with and without dysplasia/carcinoma
16. Linked color imaging improves visibility of reflux esophagitis
17. Distinct histopathological characteristics in colorectal submucosal invasive carcinoma arising in sessile serrated adenoma/polyp and conventional tubular adenoma
18. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study
19. Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration
20. The Role of the Plasminogen/Plasmin System in Inflammation of the Oral Cavity
21. A Case of Yersinia enterocolitica Enteritis Diagnosed with Erythema Nodosum
22. Epidermal Cyst in an Intrapancreatic Accessory Spleen
23. Herpes Simplex Esophageal Ulcer in an Immunocompetent Adult With Hematemesis
24. Extramural Tumor Deposits Without a Lymph Node Structure in T1 Sigmoid Colon Cancer
25. サイトカインストーム症候群における細胞外プロテアーゼの機能解明と新規治療戦略
26. Usefulness of Bifidobacterium longum BB536 in Elderly Individuals With Chronic Constipation: A Randomized Controlled Trial
27. S112 Optimal Timing and Donor-Patient Matching of Fecal Microbiota Transplantation for Ulcerative Colitis
28. The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics
29. Efficacy of cytapheresis for remission induction and dermatological manifestations of ulcerative colitis
30. Closure with clips to accelerate healing of mucosal defects caused by colorectal endoscopic submucosal dissection
31. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases
32. Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis
33. AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
34. A case of ischemic enteritis with intestinal stenosis diagnosed using single-balloon endoscopy
35. 106: THE USEFULNESS OF BIFIDOBACTERIUM LONGUM BB536 INTAKE IN ELDERLY PATIENTS WITH CHRONIC CONSTIPATION: A PROSPECTIVE RANDOMIZED, DOUBLE-BLIND TRIAL
36. Efficacy of cytapheresis for induction therapy and extra‐intestinal skin manifestations of ulcerative colitis
37. Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis
38. Prospective clinical trial of traction device-assisted endoscopic submucosal dissection of large superficial colorectal tumors using the S–O clip
39. Frequent occurrence of fever in patients who have undergone endoscopic submucosal dissection for colorectal tumor, but bacteremia is not a significant cause
40. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis
41. Overexpression of a 60-kDa heat shock protein enhances cytoprotective function of small intestinal epithelial cells
42. Roles of the angiocrine system in cancer progression
43. Histopathologic Features of Immune-related Adverse Events in the Gastrointestinal Tract: A Case of Severe Acute Respiratory Syndrome Coronavirus 2 and Cytomegalovirus Infection in a Patient with Lung Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors
44. Nicotine Oral Administration Attenuates DSS-Induced Colitis Through Upregulation of Indole in the Distal Colon and Rectum in Mice
45. Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field
46. Pretreatment prediction of symptom response to proton pump inhibitor therapy
47. Synthetic triglyceride containing an arachidonic acid branch (8A8) prevents lipopolysaccharide-induced liver injury
48. Target molecules of molecular chaperone (HSP70 family) in injured gastric mucosa in vivo
49. Endoscopic submucosal dissection of large colorectal tumors by using a novel spring-action S-O clip for traction (with video)
50. Development and clinical usability of a new traction device “medical ring” for endoscopic submucosal dissection of early gastric cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.